Global Programme to Eliminate Lymphatic Filariasis: The Processes Underlying Programme Success

PLoS Neglected Tropical Diseases

Volumn 8, Issue 12, 2014, Pages

  Ichimori, Kazuyo ^a   King, Jonathan D ^a   Engels, Dirk ^a   Yajima, Aya ^a   Mikhailov, Alexei ^a   Lammie, Patrick ^b,c   Ottesen, Eric A ^c,d  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Task Force for Global Health   (United States)

^d RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRUGIA MALAYI; BRUGIA TIMORI; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; ECONOMIC ASPECT; HEALTH PROGRAM; HUMAN; LYMPHATIC FILARIASIS; MALARIA; MORBIDITY; PRACTICE GUIDELINE; PROPHYLAXIS; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION; WUCHERERIA BANCROFTI;

EID: 84925948679     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003328     Document Type: Article

References (48)

1. WHO (2012) Global programme to eliminate lymphatic filariasis: progress report, 2011. Wkly Epidemiology Red 87: 346–356 Available: http://www.who.int/wer/2012/wer8737.pdf. Accessed 14 January 2014.
2. WHO (2010) Progress report 2000–2009 and strategic plan 2010–2020 of the global programme to eliminate lymphatic filariasis: halfway towards eliminating lymphatic filariasis. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2010/9789241500722_eng.pdf. Accessed 14 January 2014.
3. Shi Zongjun (1994) Study on the transmission threshold of filariasis. Chinese Journal of Parasitology and Parasitic Diseases 12: 1–6.
4. WHO (2012) Transmission assessment surveys in the global programme to eliminate lymphatic filariasis. WHO position statement. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/77690/1/WHO_HTM_NTD_PCT_2012_9_eng.pdf. Accessed 14 January 2014.
5. WHO (1999) Building partnerships for lymphatic filariasis: Strategic plan. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/66252/1/WHO_FIL_99.198.pdf?ua=1. Accessed 2014 January 14.
6. Ottesen EA, (2000) The Global Programme to Eliminate Lymphatic Filariasis. Trop Med Int Health 5: 591–594.
7. Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW, (2006) Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol 22: 226–233.
8. Bockarie JM, Pederson EM, White GB, Michael E, (2009) Role of vector control in the Global Programme to Eliminate Lymphatic Filariasis. Annu Rev Entomol 54: 469–487.
9. WHO (2013) Practical entomology in the global programme to eliminate lymphatic filariasis: a handbook for national elimination programmes. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/87989/1/9789241505642_eng.pdf. Accessed 14 January 2014.
10. Mackenzie CD, Lazarus WM, Mwakitalu ME, Mwingira U, Malecela MN, (2009) Lymphatic filariasis: patients and the global elimination programme. Ann Trop Med Parasitol 103 Suppl 1: S41–51.
11. Durrheim DN, Wynd S, Liese B, Gyapong JO, (2004) Lymphatic filariasis endemicity - an indicator of poverty? Trop Med Int Health 9: 43–845.
12. Molyneux D, (2003) Lymphatic filariasis (elephantiasis) elimination: a public health success and development opportunity. Filaria J 2: 13.
13. Burkot T, Ichimori I, (2002) The PacELF programme: will mass drug administration be enough? Trends Parasitol 18: 109–115.
14. Richards FO, Emukah E, Graves PM, Nkwocha O, Nwankwo L, et al. (2013) Community-wide distribution of long lasting insecticidal nets can halt transmission of lymphatic filariasis in southeast Nigeria. Am J Trop Med Hyg 89: 578–87.
15. Reimer LJ, Thomsen EK, Tisch DJ, Henry-Halldin CN, Zimmerman PA, et al. (2013) Insecticidal bed nets and filariasis transmission in Papua New Guinea. New Engl J Med 369: 745–53.
16. Pedersen EM, Stolk WA, Laney SJ, Michael E, (2009) The role of monitoring mosquito infection in the Global Programme to Eliminate Lymphatic Filariasis. Trends Parasitol 25: 319–27.
17. Boussinesq M, Gardon J, Gardon-Wendel N, Chippaux J-P, (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2: S4.
18. WHO (2012) Provisional strategy for interrupting lymphatic filariasis transmission in loiasis-endemic countries: report of a meeting on lymphatic filariasis, malaria and integrated vector management, Accra, Ghana, 5–9 March 2012. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/75139/3/WHO_HTM_NTD_PCT_2012.6_eng.pdf. Accessed 14 January 2014.
19. WHO (2013) Report of the sixth meeting of the WHO Strategic and Technical Advisory Group for Neglected Tropical Diseases. WHO headquarters, Geneva, 29–30 April 2013. Geneva: World Health Organization. Available: http://www.who.int/neglected_diseases/NTD_STAG_Report_2013.pdf. Accessed 14 January, 2014.
20. WHO (2011) Position statement on managing morbidity and preventing disability in the global programme to eliminate lymphatic filariasis. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/hq/2011/WHO_HTM_NTD_2011.8_eng.pdf. Accessed 14 January 2014.
21. WHO (2013) Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/85347/1/9789241505291_eng.pdf. Accessed 14 January 2014.
22. Noroes J, Dreyer G, (2010) A mechanism for chronic filarial hydrocele with implications for its surgical repair. PLoS Negl Trop Dis 4: e695.
23. WHO (2011) Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. Geneva: World Health Organization. Available: http://apps.who.int/iris/bitstream/10665/44580/1/9789241501484_eng.pdf. Accessed 14 January 2014.
24. Baker MC, Mathieu E, Fleming FM, Deming M, King JD, et al. (2010) Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework. Lancet 375: 231–38.
25. El-Setouhy M, Abd Elaziz KM, Helmy H, Farid HA, Kamal HA, et al. (2007) The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg 77: 1069–73.
26. Kyelem D, Biswas G, Bockarie MJ, Bradley MH, El-Setouhy M, et al. (2008) Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg 79: 480–484.
27. Chu BK, Deming M, Biritwum NK, Bougma WR, Dorkenoo AM, et al. (2013) Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl Trop Dis 7: e2584.
28. Solomon AW, Engels D, Bailey RL, Blake IM, Brooker S, et al. (2012) A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target profiles. PLoS Negl Trop Dis 6: e1746.
29. Linehan M, Hanson C, Weaver A, Baker M, Kabore A, et al. (2011) Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: proving the feasibility at national scale. Amer J Trop Med Hyg 84: 5–14.
30. Hanson C, Weaver A, Zoerhoff K, Kabore A, Linehan M, et al. (2012) Integrated implementation of programs targeting neglected tropical diseases through preventive chemotherapy: identifying best practices to roll out programs at national scale. Am J Trop Med Hyg 86: 508–13.
31. Molyneux DH, Hopkins A, Bradley MH, Kelly-Hope LA, (2014) Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms. Parasit Vectors 7: e363.
32. WHO (2013) Rolling out and scaling up integrated preventive chemotherapy for selected neglected tropical diseases. Wkly Epidemiol Rec 88: 161–166 Available: http://www.who.int/wer/2013/wer8816.pdf. Accessed 14 January 2014.
33. Brady MA, Hooper PJ, Ottesen EA, (2006) Projected benefits from integrating NTD programs in sub-Saharan Africa. Trends Parasitol 22: 285–91.
34. Dreyer G, Addiss D, Dreyer P, Noroes J (2002) Basic lymphoedema management: Treatment and prevention of problems associated with lymphatic filariasis. Hollis: Hollis Publishing Co. pp. 112.
35. Capuano GP, Capuano C, (2012) Surgical management of morbidity due to lymphatic filariasis: the usefulness of a standardized international clinical classification of hydroceles. Trop Biomed 29: 24–38.
36. Thomas G, Richards FO, JrEigege A, Dakum NK, Azzuwut MP, et al. (2009) A pilot program of mass surgery weeks for treatment of hydrocele due to lymphatic filariasis in central Nigeria,. Amr J Trop Med Hyg 80: 447–51.
37. WHO (2008) Position statement on integrated vector management. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/hq/2008/WHO_HTM_NTD_VEM_2008.2_eng.pdf. Accessed 14 January 2014.
38. WHO (2011) Position statement on integrated vector management to control malaria and lymphatic filariasis. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/hq/2011/WHO_HTM_NTD_2011.2_eng.pdf. Accessed 14 January 2014.
39. Mangling S, Bangs MJ, Pothikasikorn J, Chareonviriyaphap T, (2010) Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect Genet Evol 10: 159–77.
40. Burkot TR, Garner P, Paru R, Dagoro H, Barnes A, et al. (1990) Effects of untreated bed nets on the transmission of Plasmodium falciparum, P. vivax and Wuchereria bancrofti in Papua New Guinea. Trans Roy Soc Trop Med Hyg 84: 773–79.
41. Galvez Tan JZ, (2003) The elimination of lymphatic filariasis: a strategy for poverty alleviation and sustainable development – perspectives from the Philippines. Filaria J 2: 12.
42. Gustavsen KM, Bradley MH, Wright AL, (2009) GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis. Ann Trop Med Parasitol 103 Suppl 1: S1–5.
43. WHO (2002) Report of the third meeting of TAG-ELF, Hotel Beauregard, Sevrier-Annecy, France, 19–22 March 2002. Geneva: World Health Organization.
44. WHO (2010) Working to overcome the global impact of neglected tropical diseases: first WHO report on neglected tropical diseases. Geneva: World Health Organization. Available: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf. Accessed 14 January 2014.
45. WHO. PCT Databank. Available: http://www.who.int/neglected_diseases/preventive_chemotherapy/lf/en/. Accessed 10 July 2013.
46. Ottsen EA, Hooper PJ, Bradley M, Biwas G, (2008) The global programme to eliminate lymphatic filariasis: health impact after 8 years. PLoS Negl Trop Dis 8: e317.
47. Chu BK, Hooper PJ, Bradley MH, MacFarland DA, Ottesen EA, (2010) The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis. PLoS Negl Trop Dis 4: e708.
48. Oscar R, Lemoine JF, Direny AN, Beau de Rochars VE, Poirier MJ, et al. (2014) Haiti national program for the elimination of lymphatic filariasis – a model of success in the face of adversity. PLoS Negl Trop Dis 8: e2915.